Mark S Shearman

EDIT

Mark S Shearman serves as EVP, CHIEF SCIENTIFIC OFFICER at Editas Medicine, Inc. (EDIT). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$78.7K

Net Position

Net Seller

$78.7K

Companies Traded

EDIT

Active Period

Jun 2022 – Feb 2023

2 total trades

Most Recent

Sell EDIT

Feb 13, 2023 · $27.0K

Mark S Shearman's Insider Trading at Editas Medicine, Inc. (EDIT)

Buys

0 · $0.00

Sells

2 · $78.7K

Total Shares Bought

Total Shares Sold

7,935

EDIT Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 13, 2023↗	Sell	2,790	$9.67	$27.0K	0
Jun 15, 2022↗	Sell	5,145	$10.06	$51.7K	0

Related Insiders

Linda Burkly

officer: EVP, CHIEF SCIENTIFIC OFFICER

EDITSell · Mar 3, 2026

Gilmore Neil O'Neill

director, officer: CEO

EDITSell · Mar 3, 2026

Amy Parison

officer: SVP, Chief Financial Officer

EDITSell · Mar 3, 2026

Linda Burkly

EVP, CHIEF SCIENTIFIC OFFICER

EDITSell · Dec 3, 2025

Gilmore Neil O'Neill

CEO

EDITSell · Dec 3, 2025

Amy Parison

SVP, Chief Financial Officer

EDITSell · Dec 3, 2025

Explore More Insider Trading Data

EDIT Insider Trading Activity

View all insider trades at Editas Medicine, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity